Author: Matthew Nelson|| Date Published: December 16, 2019
McKesson (NYSE: MCK) has received a potential eight-year contract of undisclosed value to provide pharmaceutical supplies to outpatient clinics, medical centers and the Department of Veterans Affairs™ consolidated mail outpatient pharmacies.
Efforts under the contract are intended to support over 750 sites and seven CMOPs operated by the VA, the companysaid Thursday.
Contract work has a base period of two years starting in August and could extend to six more years if all options are exercised.
œWe are honored to once again be selected for the important responsibility of serving those who serve us and providing quality care for our veterans, said Brian Tyler, CEO at McKesson.
Radiance Technologies has elevated Darien Hammett to chief operating officer, placing him in charge of daily operations and execution across the company.…
latter’sRocket Lab announced Tuesday it has completed the acquisition of Mynaric, a laser-optical communications terminal provider, in a $155.3 million…
GreyNoise Intelligence has launched a command-and-control detection capability designed to give federal agencies earlier visibility into compromised infrastructure. GreyNoise’s new…
Textron Aviation Defense has been awarded a five-year, $150 million contract to provide sustaining engineering and program management, or SEPM, services…
